The Life Raft Group is pleased to announce the release of the ninth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as a comprehensive and authoritative resource of scientifically valid information for physicians and allied health care professionals regarding advances in the diagnosis and treatment of GIST and other sarcomas. Editorial content focuses on the impact of translational research in oncology and gastroenterology relating to GIST and other sarcomas. As the official medical journal of the Life Raft Group, it also provides a forum for GIST patient advocacy. It is published quarterly.
In this issue of the GIST Cancer Journal
Dr. Jonathan Trent, editor-in-chief, discusses comparing and contrasting GIST with other types of sarcomas and looking into “broadening our base” in his editor’s memo Exploring the Parallel Universe of GIST and Related Sarcomas. Diagnosis and management of these diseases share a common bond and we can look forward to collaboration at conferences such as ESMO to leverage these findings.
Peer-reviewed articles selected by Dr. Trent are summarized in the section Journal Club and Sarcoma-Related News From Scientific, Web-Based Sources and include neoadjuvant therapy for soft-tissue sarcomas, targeting protein kinases to reverse multidrug resistance, and other relevant news.
Imaging Strategies to Detect Recurrent GIST After Surgery: Controversies, Consensus and Guidelines by Dr. Wilbur B. Bowne focuses on new insights and perspectives on imaging for GIST.
Dr. Trent also provides a report from the 6th ESMO Sarcoma & GIST Conference, Recapping Pivotal Issues and Strategies in Management of GIST.
Please visit the Journal’s website to learn more and to read articles from the current issue. Print copies and article reprints can also be ordered via the website by contacting either firstname.lastname@example.org or email@example.com.